0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover586.11%IV214.47%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.5189Delta0.1607Gamma3.18Leverage Ratio-0.0194Theta0.0002Rho1.65Eff Leverage0.0017Vega
Precigen Stock Discussion
Precigen Receives Orphan Drug Designation For PRGN-2012 For Treatment Of Recurrent Respiratory Papillomatosis From The European Commission
$Advanced Micro Devices(AMD.US)$ $Aridis Pharmaceuticals(ARDS.US)$ $Alarum Technologies(ALAR.US)$ $180 Life Sciences(ATNF.US)$ $First Wave BioPharma(FWBI.US)$ $IBM Corp(IBM.US)$ $MasterCard(MA.US)$ $Microsoft(MSFT.US)$ $Mullen Automotive(MULN.US)$ $Novo Integrated Sciences(NVOS.US)$ $Ocuphire Pharma(OCUP.US)$ $Precigen(PGEN.US)$ $Tesla(TSLA.US)$ $Minerva Surgical(UTRS.US)$
In reaction to earnings/guidance:
• $Deutsche Bank(DB.US)$ +5.6%, $Salesforce(CRM.US)$ +2.3%, $H.B. Fuller(FUL.US)$ +2.2%, $Trip.com(TCOM.US)$ +0.7%
Other news:
• $Precigen(PGEN.US)$ +3.9% (names new COO)
• $Scorpio Tankers(STNG.US)$ +2.7% (reports it purchased its common shares in the open market and exercised a purchase option for an LR2 product tanker that is currently leased)
• $Marinus Pharmaceuticals(MRNS.US)$ +1.6% (...
No comment yet